Predictions
Alacer Gold Corp.
Start price
Target price
Perf. (%)
€6.12
23.09.20
23.09.20
-
04.11.21
04.11.21
0.00%
29.05.21
29.05.21
Could be worthwhile Investment >10% per year
Merck KGaA
Start price
Target price
Perf. (%)
€124.80
23.09.20
23.09.20
-
04.11.21
04.11.21
4.17%
25.11.20
25.11.20
ROE higher than 10% per year
Low dividend yield expected
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€1.41
23.09.20
23.09.20
-
04.11.21
04.11.21
1369.50%
15.07.21
15.07.21
Risky Investment
Kandi Technologies Corp.
Start price
Target price
Perf. (%)
€4.83
23.09.20
23.09.20
€3.70
09.10.20
09.10.20
30.15%
09.10.20
09.10.20
EBIT growth >5% per year expected
Innovative
Future proof or reliable business model
Sustainability is little important
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€8.90
23.09.20
23.09.20
-
26.10.20
26.10.20
-25.84%
26.10.20
26.10.20
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€9.45
23.09.20
23.09.20
-
04.11.21
04.11.21
-47.51%
15.07.21
15.07.21
Probably not worthwhile Investment
Horizon Pharma plc
Start price
Target price
Perf. (%)
€71.00
23.09.20
23.09.20
-
26.10.20
26.10.20
-7.82%
26.10.20
26.10.20
Could be very worthwhile Investment >20% year
Inovio Pharma
Start price
Target price
Perf. (%)
€13.60
23.09.20
23.09.20
-
26.10.20
26.10.20
-31.99%
26.10.20
26.10.20
Risky Investment
Orange S.A.
Start price
Target price
Perf. (%)
€9.30
23.09.20
23.09.20
€15.00
04.11.21
04.11.21
5.51%
11.02.21
11.02.21
Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Small cyclical dependencies
Orange S.A.
Start price
Target price
Perf. (%)
€9.30
23.09.20
23.09.20
€15.00
04.11.21
04.11.21
5.51%
11.02.21
11.02.21
Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Small cyclical dependencies
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€9.21
23.09.20
23.09.20
€14.00
04.11.21
04.11.21
692.62%
05.11.21
05.11.21
Fair valuation
Some uniques
Future proof or reliable business model
B2gold Corp.
Start price
Target price
Perf. (%)
€5.52
23.09.20
23.09.20
-
04.11.21
04.11.21
-6.45%
12.11.20
12.11.20
Could be very worthwhile Investment >20% year
Below average Marketposition
Very high cyclical dependencies
Unknown brand
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€9.90
22.09.20
22.09.20
-
04.11.21
04.11.21
-49.70%
05.11.21
05.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Fiserv Inc.
Start price
Target price
Perf. (%)
€85.20
22.09.20
22.09.20
-
04.11.21
04.11.21
10.22%
06.01.21
06.01.21
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Fiserv Inc.
Start price
Target price
Perf. (%)
€85.20
22.09.20
22.09.20
-
04.11.21
04.11.21
10.22%
06.01.21
06.01.21
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Fiserv Inc.
Start price
Target price
Perf. (%)
€85.20
22.09.20
22.09.20
-
04.11.21
04.11.21
10.22%
06.01.21
06.01.21
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Salesforce.com
Start price
Target price
Perf. (%)
€207.85
21.09.20
21.09.20
-
04.11.21
04.11.21
-6.17%
01.12.20
01.12.20
Could be worthwhile Investment >10% per year
Very capable Management
Market Leader or Top 3
Very Future proof/growth oriented business model
ASML Holding N.V.
Start price
Target price
Perf. (%)
€301.65
21.09.20
21.09.20
€650.00
04.11.21
04.11.21
145.05%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€6.26
21.09.20
21.09.20
-
04.11.21
04.11.21
-17.09%
27.11.20
27.11.20
Could be worthwhile Investment >10% per year
Fair valuation
Good rating
Valuable balance sheet